Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voyager Therapeutics

3.12
+0.01000.32%
Post-market: 3.170.0500+1.60%17:50 EDT
Volume:706.84K
Turnover:2.20M
Market Cap:172.65M
PE:-2.14
High:3.17
Open:3.09
Low:3.00
Close:3.11
Loading ...

H.C. Wainwright Reaffirms Their Buy Rating on Voyager Therapeutics (VYGR)

TIPRANKS
·
Yesterday

Voyager Therapeutics Inc. Concluded Annual Stockholders Meeting

Reuters
·
06 Jun

U.S. RESEARCH ROUNDUP-Datadog, Masimo, Waters

Reuters
·
07 May

Voyager Therapeutics Q1 EPS $(0.53) Misses $(0.46) Estimate, Sales $6.47M Miss $13.56M Estimate

Benzinga
·
07 May

Voyager Therapeutics Inc: Ended Q1 With Cash Position of $295 Mln Which We Expect to Provide Runway Into Mid-2027

THOMSON REUTERS
·
07 May

Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting

GlobeNewswire
·
29 Apr

Voyager Therapeutics Inc (VYGR) Q4 2024 Earnings Call Highlights: Strong Financial Position and ...

GuruFocus.com
·
22 Apr

Promising Developments in Alzheimer’s Treatments Support Buy Rating for Voyager Therapeutics

TIPRANKS
·
10 Apr

Voyager Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
09 Apr

Promising Developments in Voyager Therapeutics’ Alzheimer’s Programs Highlight Potential of Dual Tau-Targeted Therapies

TIPRANKS
·
09 Apr

TD Cowen Keeps Their Buy Rating on Voyager Therapeutics (VYGR)

TIPRANKS
·
08 Apr

Top Executives Unload Thousands of Voyager Therapeutics Shares!

TIPRANKS
·
05 Apr

Voyager Therapeutics announces new data from two preclinical programs

TIPRANKS
·
31 Mar

Analysts Have Conflicting Sentiments on These Healthcare Companies: Teleflex (TFX) and Voyager Therapeutics (VYGR)

TIPRANKS
·
17 Mar

Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Labcorp Holdings (LH) and Arcutis Biotherapeutics (ARQT)

TIPRANKS
·
17 Mar

Voyager Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
14 Mar

Voyager Therapeutics Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
13 Mar

Voyager Therapeutics: Strong Buy Rating Backed by Strategic Partnerships and Promising Pipeline

TIPRANKS
·
13 Mar

Voyager Therapeutics: Strong Financials and Promising Pipeline Drive Buy Rating

TIPRANKS
·
12 Mar

Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
12 Mar